BioMarin Pharmaceutical Inc. (BIT:1BMRN)
Italy flag Italy · Delayed Price · Currency is EUR
49.63
0.00 (0.00%)
At close: Aug 13, 2025, 5:30 PM CET

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
NAGLAZYME
479.58M
Log In
Log In
Log In
Log In
Upgrade
NAGLAZYME Growth
9.04%
Log In
Log In
Log In
Log In
Upgrade
ALDURAZYME
183.89M
Log In
Log In
Log In
Log In
Upgrade
ALDURAZYME Growth
65.31%
Log In
Log In
Log In
Log In
Upgrade
KUVAN
120.90M
Log In
Log In
Log In
Log In
Upgrade
KUVAN Growth
-24.64%
Log In
Log In
Log In
Log In
Upgrade
FIRDAPSE
-
Log In
Log In
Log In
Log In
Upgrade
FIRDAPSE Growth
-
Log In
Log In
Log In
Log In
Upgrade
Royalty and Other
44.47M
Log In
Log In
Log In
Log In
Upgrade
Royalty and Other Growth
-1.19%
Log In
Log In
Log In
Log In
Upgrade
VIMIZIM
739.78M
Log In
Log In
Log In
Log In
Upgrade
VIMIZIM Growth
9.65%
Log In
Log In
Log In
Log In
Upgrade
BRINEURA
169.08M
Log In
Log In
Log In
Log In
Upgrade
BRINEURA Growth
2.80%
Log In
Log In
Log In
Log In
Upgrade
PALYNZIQ
355.05M
Log In
Log In
Log In
Log In
Upgrade
PALYNZIQ Growth
18.01%
Log In
Log In
Log In
Log In
Upgrade
VOXZOGO
735.09M
Log In
Log In
Log In
Log In
Upgrade
VOXZOGO Growth
37.64%
Log In
Log In
Log In
Log In
Upgrade
ROCTAVIAN
26.07M
Log In
Log In
Log In
Log In
Upgrade
ROCTAVIAN Growth
218.56%
Log In
Log In
Log In
Log In
Upgrade
Royalty and Other
44.47M
Log In
Log In
Log In
Log In
Upgrade
Royalty and Other Growth
-1.19%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
Royalty and Other
44.47M
Log In
Log In
Log In
Log In
Upgrade
Royalty and Other Growth
-1.19%
Log In
Log In
Log In
Log In
Upgrade
Royalty and Other
44.47M
Log In
Log In
Log In
Log In
Upgrade
Royalty and Other Growth
-1.19%
Log In
Log In
Log In
Log In
Upgrade
United States
924.81M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
22.23%
Log In
Log In
Log In
Log In
Upgrade
Europe
829.03M
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
19.28%
Log In
Log In
Log In
Log In
Upgrade
Latin America
378.08M
Log In
Log In
Log In
Log In
Upgrade
Latin America Growth
13.97%
Log In
Log In
Log In
Log In
Upgrade
Rest of World Revenue (Pre-Q3 2024)
-
Log In
Log In
Log In
Log In
Upgrade
Rest of World Revenue (Pre-Q3 2024) Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other
677.52M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
47.38%
Log In
Log In
Log In
Log In
Upgrade